Recurrent GBM: Clinical Trials

2 trials for Recurrent GBM, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2
Phase 11Terminated 1

Follow Recurrent GBM: new trials by email Literature Review of Recurrent GBM trials Research Report on Recurrent GBM

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Subjects With Recurrent GBM
SONALA-001 (ALA) and MR-Guided Focused Ultrasound device (MRgFUS) - Recurrent GBM
Phase 1 / Phase 2TerminatedSonALAsense, Inc.82023-02-062024-07-26
Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab
Radiation: Intra-operative Radiation Therapy - IORT, Bevacizumab - Glioblastoma, Recurrent Glioblastoma
Phase 2TerminatedXoft, Inc.122021-11-022024-04-26

Narrower conditions

Glioblastoma (2)

Broader conditions

Astrocytoma (2)  ·  Glioma (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Neoplasms, Nerve Tissue (2)  ·  Neoplasms, Neuroepithelial (2)  ·  Neuroectodermal Tumors (2)

Interventions

Bevacizumab (1)

Sponsors

SonALAsense, Inc. (1)  ·  Xoft, Inc. (1)

Countries

United States (2)

Top investigators

Corina Andresen, MD (1)  ·  Santosh Kesari, MD (1)

NIH funding

R44CA275508 (1)